Takeda Pharmaceutical Company develops, produces, and markets pharmaceuticals in various regions worldwide, including Japan, the US, and Europe. The company offers a variety of products in categories such as gastroenterology, oncology, neuroscience, and rare diseases, among others. Takeda has entered into various collaborations and licensing agreements with numerous organizations, including Neurocrine Biosciences, Ovid Therapeutics, and the University of Texas MD Anderson Cancer Center.